Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions

Laura E Watkins, Kelsey R Sprang, Barbara O Rothbaum, Laura E Watkins, Kelsey R Sprang, Barbara O Rothbaum

Abstract

Posttraumatic stress disorder (PTSD) is a chronic, often debilitating mental health disorder that may develop after a traumatic life event. Fortunately, effective psychological treatments for PTSD exist. In 2017, the Veterans Health Administration and Department of Defense (VA/DoD) and the American Psychological Association (APA) each published treatment guidelines for PTSD, which are a set of recommendations for providers who treat individuals with PTSD. The purpose of the current review article is to briefly review the methodology used in each set of 2017 guidelines and then discuss the psychological treatments of PTSD for adults that were strongly recommended by both sets of guidelines. Both guidelines strongly recommended use of Prolonged Exposure (PE), Cognitive Processing Therapy (CPT) and trauma-focused Cognitive Behavioral Therapy (CBT). Each of these treatments has a large evidence base and is trauma-focused, which means they directly address memories of the traumatic event or thoughts and feelings related to the traumatic event. Finally, we will discuss implications and future directions.

Keywords: cognitive behavioral therapy; cognitive processing therapy; evidence-based medicine; posttraumatic stress disorder; prolonged exposure; psychotherapy; treatment.

References

    1. Alonso J., Angermeyer M. C., Bernert S., Bruffaerts R., Brugha T. S., Bryson H., et al. . (2004). Prevalence of mental disorders in europe: results from the european study of the epidemiology of mental disorders. Acta Psychiatr. Scand. Suppl. 109, 21–27. 10.1111/j.1600-0047.2004.00327.x
    1. American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders. 3rd Edn. Arlington, VA: American Psychiatric Publishing.
    1. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition-Text Revision. Arlington, VA: American Psychiatric Publishing.
    1. American Psychiatric Association (2004). Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. Arlington, VA: American Psychiatric Publishing.
    1. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders. 5th Edn. Arlington, VA: American Psychiatric Publishing.
    1. American Psychological Association (2017). Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults. Washington, DC: American Psychological Association.
    1. Angelo F. N., Miller H. E., Zoellner L. A., Feeny N. C. (2008). “I need to talk about it”: a qualitative analysis of trauma-exposed women’s reasons for treatment choice. Behav. Ther. 39, 13–21. 10.1016/j.beth.2007.02.002
    1. Asukai N., Saito A., Tsuruta N., Kishimoto J., Nishikawa T. (2010). Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: a randomized controlled study. J. Trauma. Stress 23, 744–750. 10.1002/jts.20589
    1. Becker C. B., Darius E., Schaumberg K. (2007). An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder. Behav. Res. Ther. 45, 2861–2871. 10.1016/j.brat.2007.05.006
    1. Blanchard E. B., Hickling E. J., Devineni T., Veazey C. H., Galovski T. E., Mundy E., et al. . (2003). A controlled evaluation of cogntive behavioral therapy for posttraumatic stress in motor vehicle accidnet survivors. Behav. Res. Ther. 41, 79–96. 10.1016/s0005-7967(01)00131-0
    1. Bradley R., Greene J., Russ E., Dutra L., Westen D. (2005). A multidimensional meta-analysis of psychotherapy for PTSD. Am. J. Psychiatry 162, 214–227. 10.1176/appi.ajp.162.2.214
    1. Bryant R. A., Moulds M. L., Guthrie R. M., Dang S. T., Mastrodomenico J., Nixon R. D., et al. . (2008). A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J. Consult. Clin. Psychol. 76, 695–703. 10.1037/a0012616
    1. Bryant R. A., Moulds M. L., Guthrie R. M., Dang S. T., Nixon R. D. V. (2003). Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J. Consult. Clin. Psychol. 71, 706–712. 10.1037/0022-006x.71.4.706
    1. Chard K. M. (2005). An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J. Consult. Clin. Psychol. 73, 965–971. 10.1037/0022-006x.73.5.965
    1. Chard K. M., Ricksecker E. G., Healy E. T., Karlin B. E., Resick P. A. (2012). Dissemination and experience with cognitive processing therapy. J. Rehabil. Res. Dev. 49, 667–678. 10.1682/jrrd.2011.10.0198
    1. Chard K. M., Schumm J. A., McIlvain S. M., Bailey G. W., Parkinson R. B. (2011). Exploring the efficacy of a residential treatment program incorporating cognitive processing therapy-cognitive for veterans with PTSD and traumatic brain injury. J. Trauma. Stress 24, 347–351. 10.1002/jts.20644
    1. Chard K. M., Schumm J. A., Owens G. P., Cottingham S. M. (2010). A comparison of OEF and OIF veterans and Vietnam veterans receiving cognitive processing therapy. J. Trauma. Stress 23, 25–32. 10.1002/jts.20500
    1. Cusack K., Jonas D. E., Forneris C. A., Wines C., Sonis J., Middleton J. C., et al. . (2016). Psychological treatments for adults with posttraumatic stress disorder: a systematic review and meta-analysis. Clin. Psychol. Rev. 43, 128–141. 10.1016/j.cpr.2015.10.003
    1. de Kleine R. A., Hendriks G. J., Kusters W. J., Broekman T. G., van Minnen A. (2012). A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol. Psychiatry 71, 962–968. 10.1016/j.biopsych.2012.02.033
    1. Dunlop B. W., Mansson E., Gerardi M. (2012). Pharmacological innovations for posttraumatic stress disorder and medication-enhanced psychotherapy. Curr. Pharm. Des. 18, 5645–5658. 10.2174/138161212803530899
    1. Ehlers A., Clark D. M. (2000). A cogntive model of posttraumatic stress disorder. Behav. Res. Ther. 38, 319–345. 10.1016/S0005-7967(99)00123-0
    1. Ehlers A., Clark D. M., Hackmann A., McManus F., Fennell M. (2005). Cognitive therapy for post-traumatic stress disorder: development and evaluation. Behav. Res. Ther. 43, 413–431. 10.1016/j.brat.2004.03.006
    1. Ehlers A., Clark D. M., Hackmann A., McManus F., Fennell M., Herbert C., et al. . (2003). A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch. Gen. Psychiatry 60, 1024–1032. 10.1001/archpsyc.60.10.1024
    1. Feeny N. C., Zoellner L. A., Mavissakalian M. R., Roy-Byrne P. P. (2009). What would you choose? Sertraline or prolonged exposure in a community and PTSD treatment seeking women. Depress. Anxiety 26, 724–731. 10.1002/da.20588
    1. Foa E. B., Hembree E. A., Rothbaum B. O. (2007). Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences. New York, NY: Oxford University Press.
    1. Foa E. B., Kozak M. J. (1985). “Treatment of anxiety disorders: implications for psychopathology,” in Anxiety and the Anxiety Disorders, eds Tuma A. H., Maser J. D. (Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.), 421–452.
    1. Foa E. B., Kozak M. J. (1986). Emotional processing of fear: exposure to corrective information. Psychol. Bull. 99, 20–35. 10.1037/0033-2909.99.1.20
    1. Foa E. B., Keane T. M., Friedman M. J., Cohen J. A. (2009). Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. 2nd Edn. New York, NY: The Guilford Press.
    1. Foa E. B., McLean C. P., Zang Y., Rosenfield D., Yadin E., Yarvis J. S., et al. . (2018). Effect of prolonged exposure therapy delivered over 2 weeks vs. 8 weeks vs. present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA 319, 354–364. 10.1001/jama.2017.21242
    1. Fonzo G. A., Goodkind M. S., Oathes D. J., Zaiko Y. V., Harvey M., Peng K. K., et al. . (2017). PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am. J. Psychiatry 174, 1163–1174. 10.1176/appi.ajp.2017.16091072
    1. Galovski T., Lyons J. A. (2004). Psychological sequelae of combat violence: a review of the impact of PTSD on the veteran’s family and possible interventions. Aggression Violent Behav. 9, 477–501. 10.1016/s1359-1789(03)00045-4
    1. Harvey M. M., Rauch S. A. M., Zalta A. K., Sornborger J., Pollack M. H., Rothbaum B. O., et al. (2017). Intensive treatment models to address posttraumatic stress among post-9/11 warriors: the warrior care network. Focus 15, 378–383. 10.1176/appi.focus.20170022
    1. Hembree E. A., Foa E. B., Dorfan N. M., Street G. P., Kowalski J., Tu X. (2003). Do patients drop out prematurely from exposure therapy for PTSD? J. Trauma. Stress 16, 555–562. 10.1023/b:jots.0000004078.93012.7d
    1. Hendriks L., de Kleine R. A., Broekman T. G., Hendriks G. J., van Minnen A. (2018). Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma and multiple treatment attempts. Eur. J. Psychotraumatol. 9:1425574. 10.1080/20008198.2018.1425574
    1. Imel Z. E., Laska K., Jakupcak M., Simpson T. L. (2013). Meta-analysis of dropout in treatments for posttraumatic stress disorder. J. Consult. Clin. Psychol. 81, 394–404. 10.1037/a0031474
    1. Institute of Medicine (2007). Treatment of PTSD: Assessment of the Evidence. Washington, DC: National Academies Press.
    1. Institute of Medicine (2011a). Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press.
    1. Institute of Medicine (2011b). Finding What Works in Health Care: Standards for Systematic Reviews. Washington, DC: The National Academies Press.
    1. Institute of Medicine (2014). Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Final Assessment. Washington, DC: The National Academies Press.
    1. Jonas D. E., Cusack K., Forneris C. A., Wilkins T. M., Sonis J., Middleton J. C., et al. (2013). Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD): Comparative Effectiveness Review No. 92. (Prepared by the RTI International-University of North Carolina Evidence-Based Practice Center Under Contract No. 290-2007-10056-I). AHRQ Publication No. 13-EHC011-EF. Rockville, MD: Agency for Healthcare Research and Quality.
    1. Kilpatrick D. G., Resnick H. S., Milanak M. E., Miller M. W., Keyes K. M., Friedman M. J. (2013). National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J. Trauma. Stress 26, 537–547. 10.1002/jts.21848
    1. Koch S. B., van Zuiden M., Nawijn L., Frijling J. L., Veltman D. J., Olff M. (2014). Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear inhibition processes. Psychoneuroendocrinology 40, 242–256. 10.1016/j.psyneuen.2013.11.018
    1. Kozel F. A., Motes M. A., Didehbani N., DeLaRosa B., Bass C., Schraufnagel C. D., et al. . (2018). Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J. Affect. Disord. 229, 506–514. 10.1016/j.jad.2017.12.046
    1. Kubany E. S., Hill E. E., Owens J. A., Iannce-Spencer C., McCaig M. A., Tremayne K. J., et al. . (2004). Cognitive trauma therapy for battered women with PTSD (CTT-BW). J. Consult. Clin. Psychol. 72, 3–18. 10.1037/0022-006x.72.1.3
    1. Marks I., Lovell K., Noshirvani H., Livanou M., Thrasher S. (1998). Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Cochrane Database Syst. Rev. 55:CD004780. 10.1002/14651858.CD004780.pub3
    1. McKay D. (2017). Clinical practice guidelines: a clear public good, the doubters notwithstanding. Available online at:
    1. Mithoefer M. C., Wagner M. T., Mithoefer A. T., Jerome L., Doblin R. (2011). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J. Psychopharmacol. 25, 439–452. 10.1177/0269881110378371
    1. National Institute for Health and Clinical Excellence (2005). Posttraumatic Stress Disorder. London: Gaskell.
    1. Norris F., Sloane L. B. (2007). “The epidemiology of trauma and PTSD,” in Handbook of PTSD: Science and Practice, eds Friedman M. J., Keane T. M., Resick P. A. (New York, NY: Guilford Press; ), 78–98.
    1. Power K., McGoldrick T., Brown K., Buchanan R., Sharp D., Swanson V., et al. (2002). A controlled comparison of eye movement desensitization and reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder. Clin. Psychol. Psychother. 9, 299–318. 10.1002/cpp.341
    1. Powers M. B., Halpern J. M., Ferenschak M. P., Gillihan S. J., Foa E. B. (2010). A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin. Psychol. Rev. 30, 635–641. 10.1016/j.cpr.2010.04.007
    1. Reger G. M., Durham T. L., Tarantino K. A., Luxton D. D., Holloway K. M., Lee J. A. (2013). Deployed soldiers’ reactions to exposure and medication treatments for PTSD. Psychol. Trauma 5, 309–316. 10.1037/a0028409
    1. Resick P. A., Galovski T. E., Uhlmansiek M. O., Scher C. D., Clum G. A., Young-Xu Y. (2008). A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J. Consult. Clin. Psychol. 76, 243–258. 10.1037/0022-006X.76.2.243
    1. Resick P. A., Monson C. M., Chard K. M. (2017). Cognitive Processing Therapy for PTSD: A Comprehensive Manual. New York, NY: Guilford Press.
    1. Resick P. A., Nishith P., Weaver T. L., Astin M. C., Feuer C. A. (2002). A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in femail rape victims. J. Consult. Clin. Psychol. 70, 867–879. 10.1037/0022-006x.70.4.867
    1. Resick P. A., Schnicke M. K. (1992). Cognitive processing therapy for sexual assault victims. J. Consult. Clin. Psychol. 60, 748–756. 10.1037/0022-006x.60.5.748
    1. Resick P. A., Williams L. F., Suvak M. K., Monson C. M., Gradus J. L. (2012). Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. J. Consult. Clin. Psychol. 80, 201–210. 10.1037/a0026602
    1. Rosenbaum S., Sherrington C., Tiedemann A. (2015). Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr. Scand. 131, 350–359. 10.1111/acps.12371
    1. Rothbaum B. O., Price M., Jovanovic T., Norrholm S. D., Gerardi M., Dunlop B. W., et al. . (2014). A randomized, double-blind evaluation of D-Cycloserine or Alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans. Am. J. Psychiatry 171, 640–648. 10.1176/appi.ajp.2014.13121625
    1. Schnurr P. P., Friedman M., Engel C. C., Foa E. B., Shea M. T., Chow B. K., et al. . (2007). Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA 297, 820–830. 10.1001/jama.297.8.820
    1. Schumm J. A., Walter K. H., Bartone A. S., Chard K. M. (2015). Veteran satisfaction and treatment preferences in response to a posttraumatic stress disorder specialty clinic orientation group. Behav. Res. Ther. 69, 75–82. 10.1016/j.brat.2015.04.006
    1. Shedler J. (2017). Selling bad therapy to trauma victims: patients and therapists should ignore new guidelines for treating trauma. Available online at:
    1. Sledjeski E. M., Speisman B., Dierker L. C. (2008). Does number of lifetime traumas explain the relationship between PTSD and chronic medical conditions? Answers from the National Comorbidity Survey-Replication (NCS-R). J. Behav. Med. 31, 341–349. 10.1007/s10865-008-9158-3
    1. Smith M. W., Schnurr P. P., Rosenheck R. A. (2005). Employment outcomes and PTSD symptom severity. Ment. Health Serv. Res. 7, 89–101. 10.1007/s11020-005-3780-2
    1. Steenkamp M. M. (2016). True evidence-based care for posttraumatic stress disorder in military personnel and veterans. JAMA Psychiatry 73, 431–432. 10.1001/jamapsychiatry.2015.2879
    1. Steenkamp M. M., Litz B. T., Hoge C. W., Marmar C. R. (2015). Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA 314, 489–500. 10.1001/jama.2015.8370
    1. Tarrier N., Liversidge T., Gregg L. (2006). The acceptability and prefernce for the psychological treatment of PTSD. Behav. Res. Ther. 44, 1643–1656. 10.1016/j.brat.2005.11.012
    1. Taylor S., Thordarson D. S., Maxfield L., Fedoroff I. C., Lovell K., Ogrodniczuk J. (2003). Comparative efficacy, speed and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J. Consult. Clin. Psychol. 71, 330–338. 10.1037/0022-006x.71.2.330
    1. VA/DoD Clinical Practice Guideline Working Group (2017). VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Washington, DC: VA Office of Quality and Performance.
    1. VA/DoD Evidence-Based Practice Working Group (2013). The guideline for guidelines. Available online at:
    1. Watts B. V., Schnurr P. P., Mayo L., Young-Xu Y., Weeks W. B., Friedman M. J. (2013). Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J. Clin. Psychiatry 74, e541–e550. 10.4088/JCP.12r08225
    1. Wisco B. E., Marx B. P., Wolf E. J., Miller M. W., Southwick S. M., Pietrzak R. H. (2014). Posttraumatic stress disorder in the US veteran population: results from the National Health and Resilience in Veterans Study. J. Clin. Psychiatry 75, 1338–1346. 10.4088/jcp.14m09328
    1. Zoellner L. A., Feeny N. C., Bittinger J. (2009). What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure. Exp. Neurol. 40, 455–467. 10.1016/j.jbtep.2009.06.001

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever